🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07285252
Enrolling by invitation Not applicable

Evaluating Non-Invasive Haptics During Extreme Exercise

NCT07285252 · tracked via the Priya Life Science UK tracker
Sponsor
SuperPatch Limited LLC
Phase
Not applicable
Started
2025-01-05
Last updated
2026-08-20

Condition(s) studied

VO2maxLactate ThresholdLactate

Investigational drug(s) / intervention(s)

Victory Patch with Haptic Vibrotactile Trigger TechnologySham patch

Victory Patch with Haptic Vibrotactile Trigger Technology: Active Patch with Haptic Vibrotactile Trigger Technology

Sham patch: Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology

Study summary

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years and over, that participate in recreational to competitive distance running (\>2 structured runs per week), that were able to complete maximal treadmill exercise safely and were able to attend three laboratory visits were invited to participate. Exclusion Criteria: * Adults with a contraindications to high-intensity treadmill exercise, cardiovascular, metabolic, or musculoskeletal conditions limiting participation, reported use of performance-enhancing drugs, pregnancy, known allergy to adhesives, or current use of neuromodulatory or haptic devices

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Altitude Centre London UK

More SuperPatch Limited LLC trials in the UK

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07285252 on ClinicalTrials.gov ↗ ← All trials in the UK